# Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)

> **NCT02905214** · — · COMPLETED · sponsor: **B. Braun Melsungen AG** · enrollment: 4369 (actual)

## Conditions studied

- Coronary Artery Disease (CAD)

## Interventions

- **DEVICE:** stenting with the Coroflex ISAR sirolimus-eluting stent

## Key facts

- **NCT ID:** NCT02905214
- **Lead sponsor:** B. Braun Melsungen AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-12
- **Final completion:** 2021-12
- **Target enrollment:** 4369 (ACTUAL)
- **Last updated:** 2022-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02905214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02905214, "Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02905214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*